"10.1371_journal.pone.0087746","plos one","2014-02-03T00:00:00Z","Line S Tarpgaard; Tormod K Guren; Bengt Glimelius; Ib J Christensen; Per Pfeiffer; Elin H Kure; Halfdan Sorbye; Tone Ikdahl; Mette Yilmaz; Julia S Johansen; Kjell Magne Tveit","Department of Oncology, Odense University Hospital, Odense, Denmark and University of Southern Denmark, Odense, Denmark; Department of Oncology, Oslo University Hospital, Oslo, Norway; Departments of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden and Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden; The Finsen Laboratory, Copenhagen University Hospital, Copenhagen, Denmark and Biotech Research and Innovation Center (BRIC), University of Copenhagen, Copenhagen, Denmark; Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway; Department of Oncology, Aalborg Hospital, Aalborg, Denmark; Departments of Oncology and Medicine, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark","Conceived and designed the experiments: TKG BG PP EHK HS TI KMT. Performed the experiments: LST TKG BG PP EHK TI JSJ KMT. Analyzed the data: LST TKG BG IJC PP JSJ KMT. Contributed reagents/materials/analysis tools: TKG BG PP EHK HS TI MY JSJ KMT. Wrote the paper: LST TKG BG IJC PP EHK HS TI MY JSJ KMT.","Quidel provided the study with some of the YKL-40 ELISA kits at a reduced price. The NORDIC VII Study received funding by Merck KGaA and Sanofi-Aventis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2014","02","Line S Tarpgaard","LST",11,TRUE,7,8,7,11,TRUE,TRUE,FALSE,0,NA,FALSE
